A5025568909- Peripheral Neuropathies and Disorders
- Autoimmune Neurological Disorders and Treatments
- COVID-19 Impact on Reproduction
- Vector-Borne Animal Diseases
- RNA regulation and disease
- Psychosomatic Disorders and Their Treatments
- Renal Diseases and Glomerulopathies
- Myasthenia Gravis and Thymoma
- Vector-borne infectious diseases
- Temporomandibular Joint Disorders
- Pharmacological Effects and Toxicity Studies
- Epilepsy research and treatment
- Parkinson's Disease and Spinal Disorders
- COVID-19 Clinical Research Studies
- Facial Nerve Paralysis Treatment and Research
- Viral Infections and Vectors
- Neuroinflammation and Neurodegeneration Mechanisms
Karl Landsteiner University of Health Sciences
2018-2024
Trinity College Dublin
2024
John Radcliffe Hospital
2024
University of Oxford
2024
Universitätsklinikum Tulln
2018-2021
Background ‘Definite Neuroborreliosis (NB)’ is diagnosed with the presence of NB-specific symptoms, cerebrospinal fluid (CSF) pleocytosis and an elevated Borrelia Burgdorferi antibody index. However, some diagnostic uncertainties exist. The B-cell chemokine CXCL13 represents emerging biomarker for diagnosis treatment NB because its intrathecal concentration rises prior to index drops rapidly after antibiotic therapy. Nevertheless, due lacking prospective data, a definite cut-off still...
Prospective observations of functional recovery are lacking in patients with autoimmune encephalitis defined by antibodies against synaptic proteins and neuronal cell surface receptors.Adult a diagnosis were included into prospective registry. At 3, 6 12 months follow-up, the patients' modified Rankin Scale (mRS) was obtained.Patients stratified three groups according to their antibody (Ab) status: anti-NMDAR-Ab (n=12; group I), anti-LGI1/CASPR2-Ab (n=35; II), other (n=24; III). A comparably...